| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Iqvia Holdings Inc. (IQV) has 9 insiders with recent SEC Form 4 filings, including 1 buy and 18 sells. IQV is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 857.2K | $153.12M | - | |
| Other | 8.4K | $1.51M | - | |
| Other | 5.4K | $963.0K | - | |
| Dir | 4.7K | $845.9K | - | |
| Dir | 4.7K | $840.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | Bousbib Ari64 | See Remarks | Sale+OE | 36,564 | $222.43 | $8,132,930.52 | -4.3% | -24.9% | - | |
| Oct 29, 2025 | Sherbet Eric57 | See Remarks | Sale+OE | 4,000 | $219.70 | $878,800.00 | -12.9% | +10.7% | - | |
| Oct 29, 2025 | Bousbib Ari64 | See Remarks | Sale+OE | 56,557 | $220.33 | $12,461,119.18 | -1.1% | +10.7% | - | |
| Jul 23, 2025 | Cherofsky Keriann | See Remarks | Sell | 549 | $191.53 | $105,149.97 | -15.9% | +12.6% | - | |
| Jul 23, 2025 | Sherbet Eric57 | See Remarks | Sale+OE | 5,800 | $190.05 | $1,102,290.00 | -17.6% | +12.6% | - | |
| Dec 3, 2024 | Danhakl John G61 | Director | Buy | 1,275 | $200.58 | $255,739.50 | New | -7.8% | +13.3% | |
| Aug 27, 2024 | Sherbet Eric57 | See Remarks | Sell | 1,300 | $246.33 | $320,229.00 | -6.2% | -17.9% | -24.1% | |
| Mar 1, 2024 | Bousbib Ari64 | See Remarks | Sale+OE | 31,678 | $250.53 | $7,936,192.56 | -1.9% | -11.9% | -25.2% | |
| Feb 29, 2024 | Staub W Richard | See Remarks | Sell | 14,100 | $247.80 | $3,494,034.00 | -20.4% | -9.0% | -23.6% | |
| Feb 28, 2024 | Knightly Kevin C57 | See Remarks | Sale+OE | 8,607 | $250.17 | $2,153,175.56 | -40.4% | -9.4% | -25.5% |